Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells again...
Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma
About this item
Full title
Author / Creator
Publisher
Australia: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Australia: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
CAR-T cells are being investigated as a novel immunotherapy for glioblastoma, but clinical success has been limited. We recently described fibroblast activation protein (FAP) as an ideal target antigen for glioblastoma immunotherapy, with expression on both tumor cells and tumor blood vessels. However, CAR-T cells targeting FAP have never been inve...
Alternative Titles
Full title
Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_015396e342d8443aa4091f21f509b391
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_015396e342d8443aa4091f21f509b391
Other Identifiers
ISSN
2050-0068
E-ISSN
2050-0068
DOI
10.1002/cti2.1519
